Emergent Accumulated Other Comprehensive Income from 2010 to 2025
| EBS Stock | USD 9.07 0.97 9.66% |
Accumulated Other Comprehensive Income | First Reported 2004-12-31 | Previous Quarter -6.1 M | Current Value -8.1 M | Quarterly Volatility 6.2 M |
Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 114.2 M, Interest Expense of 74.5 M or Total Revenue of 583.9 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.018 or PTB Ratio of 1.0. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
Emergent | Accumulated Other Comprehensive Income | Build AI portfolio with Emergent Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.